¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"INTERFERON OINTMENT"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ung. unguentum; ointment; ¿¬°í
HPO high-presure oxygen; hydroperoxide; hydrophilic ointment; hypertrophic pulmonary osteoarthropathy
NSO Neosporin ointment; nucleus supraopticus
NTGO nitroglycerin ointment
oint ointment
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IFN 1-interferon
IF 2-interferon
IFN alpha Alpha interferon
alpha IFN Alpha interferon
IFN Alpha-2-interferon
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® interferon ÇÑ±Û ÀÎÅÍÆä·Ð
¼³¸í   
  ¹ÙÀÌ·¯½º¿¡ °¨¿°µÈ µ¿¹°ÀÇ ¼¼Æ÷¿¡¼­ »ý»êµÇ´Â Ç×¹ÙÀÌ·¯½º¼º ´Ü¹éÁú. ¹ÙÀÌ·¯½º¿¡ °¨¿°µÈ Á¶Á÷ÀÌ »ý»êÇϴ Ç×¹ÙÀÌ·¯½º ÀÛ¿ëÀ̳ª Ç×Á¾¾çÀۿ렵ý¸®È°¼ºÀÌ Àִ ´ç´Ü¹éÁúÀ» ¸»ÇÑ´Ù. 1957³â ¿µ±¹ ±¹¸³ÀÇÇבּ¸¼ÒÀÇ A.¾ÆÀÌÀÛ½º¿Í J.¸°µç¸Õ¿¡ ÀÇÇØ ¾Ë·ÁÁ³´Ù. À̵éÀº ¿­Ã³¸®ÇÑ ¹ÙÀÌ·¯½º¸¦ ´Þ°¿ ³»¸·ÀÇ ¼¼Æ÷¿¡ Ã³¸®Çϰí ÇÏ·ç µ¿¾È ¹è¾çÇÑ ´ÙÀ½, ¹è¾ç¾×À» ÃßÃâÇÏ¿© »õ·Î¿î ´Þ°¿ ³»¸·°ú ¼¯Àº ÈÄ, »ì¾Æ Àִ ¹ÙÀÌ·¯½º¸¦ Áý¾î³ÖÀº °á°ú, ¹ÙÀÌ·¯½ºÀÇ ºÐ¿­ÀÌ ¾ïÁ¦µÇ¾ú°í, ±× ¹è¾ç¾×À» ³ÖÁö ¾ÊÀº °æ¿ì¿¡´Â ¹ÙÀÌ·¯½º°¡ ºÐ¿­µÇ¾î ¹ø½ÄÇÏ¿´´Ù. ÀÌ ½ÇÇèÀÇ Àǹ̴ ¹ÙÀÌ·¯½º°¡ µ¿¹°¼¼Æ÷¿¡ Ä§ÀÔÇϸ頹æ¾îÀÇ ±â´ÉÀ¸·Î ±× µ¿¹°¼¼Æ÷´Â ÀÎÅÍÆä·ÐÀ» »ý»êÇÏ¿© ¹ÙÀÌ·¯½ºÀÇ ºÐ¿­À» ¸·´Â´Ù´Â °ÍÀÌ´Ù. Á¦ÀÏ ¸¹ÀÌ ¿¬±¸µÈ ºÐ¾ß´Â Àΰ£ÀÇ ÀÎÅÍÆä·ÐÀÌ´Ù. ÀÎÅÍÆä·ÐÀº ¹ÙÀÌ·¯½º°¨¿° ¹× ³»µ¶¼Ò Åõ¿©, ³ª¾Æ°¡¼­´Â Ç׿øÀڱؠµî¿¡ ¹ÝÀÀÇÏ¿© °®°¡Áö ¼¼Æ÷·ÎºÎÅÍ ¹æÃâµÈ´Ù. IFNÀ̶ó°í ¾à±â. ÇöÀç, 3Á¾(IFN-¥á, IFN-¥â, IFN-¥ã)ÀÌ ¾Ë·ÁÁ® ÀÖÀ¸¸ç °¢°¢ ÀǾàǰÀ¸·Î »ç¿ëµÇ°í ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • boric acid ointment
    ºØ»ê¿¬°í
  • gamma interferon
    °¨¸¶ÀÎÅÍÆä·Ð
  • hydrophilic ointment
    Ä£¼ö¿¬°í
  • immune interferon
    ¸é¿ªÀÎÅÍÆä·Ð
  • interferon
    ÀÎÅÍÆä·Ð
  • interferon alpha
    ÀÎÅÍÆä·Ð¾ËÆÄ
  • interferon alpha-2b
    ÀÎÅÍÆä·Ð¾ËÆÄ-2b
  • interferon omega
    ÀÎÅÍÆä·Ð¿À¸Þ°¡
  • interferon receptor
    ÀÎÅÍÆä·Ð¼ö¿ëü
  • interferon tau
    ÀÎÅÍÆä·ÐŸ¿ì
  • mercurous chloride ointment
    °¨È«¿¬°í, ¿°È­1¼öÀº¿¬°í
  • ointment
    ¿¬°í
  • ointment base
    ¿¬°í±âÁ¦
  • water soluble ointment
    ¼ö¿ë¿¬°í
  • zinc ointment
    ¾Æ¿¬¿¬°í
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alpha-interferon
    ¾ËÆÄÀÎÅÍÆä·Ð
  • ointment base
    ¿¬°í±âÁ¦
  • interferon
    ÀÎÅÍÆä·Ð
  • ointment
    ¿¬°í
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alpha-interferon
    ¾ËÆÄÀÎÅÍÆä·Ð
  • gamma interferon
    °¨¸¶ÀÎÅÍÆä·Ð
  • interferon
    ÀÎÅÍÆä·Ð
  • immune interferon
    ¸é¿ªÀÎÅÍÆä·Ð
  • interferon receptor
    ÀÎÅÍÆä·Ð¼ö¿ëü
  • boric acid ointment
    ºØ»ê¿¬°í
  • ointment base
    ¿¬°í±âÁ¦
  • hydrophilic ointment
    Ä£¼ö¿¬°í
  • mercurous chloride ointment
    °¨È«, °¨È«¿¬°í
  • ointment
    ¿¬°í
  • water soluble ointment
    ¼ö¿ë¼º¿¬°í
  • zinc ointment
    ¾Æ¿¬¿¬°í
  • zinc oxide ointment
    »êÈ­¾Æ¿¬¿¬°í
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immune interferon (Interferon-¥ã)
    ¸é¿ªÀÎÅÍÆä·Ð (°¨¸¶ÀÎÅÍÆä·Ð)
  • Hebras itch ointment
    Çìºê¶ó°³¼±¿¬°í.
  • Whitfields ointment
    ÈÜÆ®ÇÊµå ¿¬°í
  • hydrophilic ointment
    Ä£¼ö¿¬°í.
  • hydrophilic ointment
    Ä£¼ö¿¬°í
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immune interferon (Interferon-¥ã)
    ¸é¿ªÀÎÅÍÆä·Ð (°¨¸¶ÀÎÅÍÆä·Ð)
  • alpha (¥á)-interferon
    ¾ËÆÄÀÎÅÍÆä·Ð
  • beta (¥â)-interferon
    º£Å¸ÀÎÅÍÆä·Ð
  • gamma (¥ã) interferon
    °¨¸¶ÀÎÅÍÆä·Ð
  • interferon
    ÀÎÅÍÆä·Ð
  • interferon
    ÀÎÅÍÆä·Ð.
  • interferon
    ÀÎÅÍÆä·Ð
  • interferon (INF) gene
    ÀÎÅÍÆä·Ð À¯ÀüÀÚ
  • interferon (INF) receptor
    ÀÎÅÍÆä·Ð ¼ö¿ëü
  • interferon unit
    ÀÎÅÍÆä·Ð ´ÜÀ§
  • interferon, immune
    ¸é¿ªÀÎÅÍÆä·Ð (°¨¸¶ÀÎÅÍÆä·Ð)
  • interferon- a(ifn-a)
    ÀÎÅÍÆä·Ð a
  • interferon- b(ifn-b)
    ÀÎÅÍÆä·Ð b
  • interferon- g(ifn-g)
    ÀÎÅÍÆä·Ð g
  • interferon-¥á (INF-¥á)
    ¾ËÆÄÀÎÅÍÆä·Ð
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • interferon
    ÀÎÅÍÆä·Ð
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • interferon
    ÀÎÅÍÆä·Ð
  • ointment
    ¿¬°í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • interferon
    ÀÎÅÍÆä·Ð
    ¹ÙÀÌ·¯½ºÀÇ RNA¿Í ´Ü¹éÁú ÇÕ¼ºÀ» ¼±ÅÃÀûÀ¸·Î ¹æÇØÇÏ´Â Ç×¹ÙÀÌ·¯½º¼º ´Ü¹éÁúÀ» °üÀåÇÏ´Â ¼¼Æ÷ À¯ÀüÀÚÀÇ Àü»ç¿¡ ÀÇÇØ »ý¼ºµÈ ¹ÙÀÌ·¯½º ºñƯÀÌÀûÀÌ°í ¼÷ÁÖ Æ¯ÀÌÀû Ç×¹ÙÀÌ·¯½º ÀÛ¿ëÀ» ³ªÅ¸³»´Â ´ç´Ü¹éÁú ±ºÀÌ´Ù. ¶ÇÇÑ ÀÎÅÍÆä·ÐÀº ¸é¿ª Á¶Àý ±â´ÉÀ» °¡Áö¸ç ºñ¹ÙÀÌ·¯½º¼º ¼¼Æ÷³» ±â»ýüÀÇ ¼ºÀåÀ» ¾ïÁ¦ÇÒ ¼ö ÀÖ´Ù. ¹ÙÀÌ·¯½º °¨¿°, ƯÈ÷ ÀÌÁß¼â RNA ¹ÙÀÌ·¯½º, ¼¼Æ÷³» ±â»ýü, ¿ø»ýµ¿¹°, ¼¼±Õ·ù ¹× ¼¼±Õ »ý»ê¹° µîÀÌ ÀÎÅÍÆä·ÐÀÇ »ý»êÀ» ÀÚ±ØÇÒ ¼ö ÀÖ´Ù. ÀÎÅÍÆä·ÐÀº »ý»ê ¼¼Æ÷¿Í ±â´É¿¡ µû¶ó 3±ºÀ¸·Î ³ª´©Áö¸¸ ¸ðµç µ¿¹° ¼¼Æ÷´Â ÀÎÅÍÆä·ÐÀ» »ý»êÇÒ ¼ö ÀÖ°í, ¾î¶² ¼¼Æ÷´Â ÇÑ Á¾·ù ÀÌ»óÀ» »ý»êÇÑ´Ù.
  • Hebras itch ointment
    Çìºê¶ó °³¼± ¿¬°í
  • lead oleate ointment
    ´Ü¿¬ ¿¬°í
  • ointment
    ¿¬°í
    1. ÇǺο¡ µµÆ÷Çϱâ À§ÇÑ °Ö»óÀÇ ¾àÁ¦. 2. ±âÁ¦
  • ointment base
    ¿¬°í ±âÁ¦
  • ointment spatula
    ¿¬°í ÁÖ°Æ
  • ole(o)- ±â¸§°úÀÇ °ü°è¸¦ ³ªÅ¸³»´Â Á¢µÎ¾î.

    oleagenous ointment

    À¯Áö¼º ¿¬°í
    ±â¸§±â°¡ ÀÖ´Â ¿¬°í.
  • ophthalmic ointment
    ¾È ¿¬°í
  • washable ointment
    °¡¼¼¼º ¿¬°í
  • water soluble ointment
    ¼ö¿ë¼º ¿¬°í
  • water-repellent ointment
    ¹æ¼ö ¿¬°í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
antibacterial ointment A ointment (or cream) based medication that kills bacteria.
Examples include Neosporin, Bactroban, Garamycin, bacitracin, gentamicin, mupirocin, neomycin, silver sulphasalazine, chloramphenicol and clindamycin.
(27 Sep 1997)
antibiotic ointment A ointment (or cream) based medication that kills bacteria.
Examples include Neosporin, Bactroban, Garamycin, bacitracin, gentamicin, mupirocin, neomycin, silver sulphasalazine, chloramphenicol and clindamycin.
(27 Sep 1997)
blue ointment A grease-based ointment containing 20% finely divided metallic mercury, formerly widely used for local application to the skin for the destruction of body lice. Risk is associated with transdermal absorption of mercury and a local dermatitis.
Synonym: mild mercurial ointment.
(05 Mar 2000)
mild mercurial ointment A grease-based ointment containing 20% finely divided metallic mercury, formerly widely used for local application to the skin for the destruction of body lice. Risk is associated with transdermal absorption of mercury and a local dermatitis.
Synonym: mild mercurial ointment.
(05 Mar 2000)
hydrophilic ointment An ointment base consisting of 25% each of white petrolatum and stearyl alcohol, 12% propyl glycol emulsified in 37% water by 1% of lauryl sulfate; preserved with paraben. Suitable for the incorporation of numerous drugs intended for local application; a washable ointment base.
(05 Mar 2000)
ointment An ointment has an oil base whereas a cream is water-soluble. (the word ointment comes from the latin ungere meaning anoint with oil).
(12 Dec 1998)
ointment base The vehicle into which active ingredients may be incorporated. Petrolatum (which may be stiffened with wax) is the most widely used greasy ointment base and is suitable for the incorporation of oleaginous materials. Lin-containing bases will absorb water (and dissolved materials) and form water-in-oil type emulsions. Water soluble (washable) bases are often derived from polymers of ethylene glycol (PEGS); these will absorb water and ingredients dissolved in the water. Ointment bases are usually pharmacologically inert but may entrap water and serve to keep the skin from dying or to provide an emollient protective film.
(05 Mar 2000)
ointment bases Various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons; vehicles for medicinal substances intended for external application; there are four classes: hydrocarbon base, absorption base, water-removable base and water-soluble base; several are also emollients.
(12 Dec 1998)
ophthalmic ointment A special ointment for application to the eye that must be free from particles and must be nonirritating to the eye.
Synonym: eye ointment, oculentum.
(05 Mar 2000)
eye ointment A special ointment for application to the eye that must be free from particles and must be nonirritating to the eye.
Synonym: eye ointment, oculentum.
(05 Mar 2000)
alpha interferon <cytokine> Interferon which is released by leukocytes in response to a viral infection. A protein cytokine that is used as an anticancer agent.
(15 Nov 1997)
antigen interferon <cytokine> Interferon elaborated by T lymphocytes in response to either specific antigen or mitogenic stimulation.
This type II interferon can be produced by recombinant DNA technology and is similar to the interferon secreted by lymphocytes and has antiviral and antineoplastic activity.
Synonym: antigen interferon, immune interferon.
Pharmacological action: antineoplastic agent, antiviral agents.
(20 Sep 2002)
beta interferon A protein liberated by fibroblasts in response to a viral infection.
(27 Sep 1997)
receptors, interferon Specific molecular sites or structures on or in cells with which interferons react or to which they bind in order to modify the function of the cells. Interferons exert their pleiotropic effects through two different receptors. Alpha- and beta-interferon crossreact with common receptors, while gamma-interferon initiates its biological effects through its own specific receptor system.
(12 Dec 1998)
immune interferon <cytokine> Interferon elaborated by T lymphocytes in response to either specific antigen or mitogenic stimulation.
This type II interferon can be produced by recombinant DNA technology and is similar to the interferon secreted by lymphocytes and has antiviral and antineoplastic activity.
Synonym: antigen interferon, immune interferon.
Pharmacological action: antineoplastic agent, antiviral agents.
(20 Sep 2002)
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 1 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¾¾Á¦ÀÌÀÎÅÍÆä·Ð¿¬°í - »õâ
¾¾Á¦ÀÌ
Interferon
ÀϹÝÀǾàǰ | ºñ±Þ¿©
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • interferon
    ÀÎÅÍÆä·Ð(¹ÙÀÌ·¯½º Áõ½Ä ¾ïÁ¦ ¹°Áú)
  • mercurial ointment
    ¼öÀº ¿¬°í
  • ointment
    ¿¬°í
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á